
PolyPeptide Group AG
SIX:PPGN

Intrinsic Value
The intrinsic value of one
PPGN
stock under the Base Case scenario is
29.2
CHF.
Compared to the current market price of 16.7 CHF,
PolyPeptide Group AG
is
Undervalued by 43%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
PolyPeptide Group AG
Fundamental Analysis


Revenue & Expenses Breakdown
PolyPeptide Group AG
Balance Sheet Decomposition
PolyPeptide Group AG
Current Assets | 328.2m |
Cash & Short-Term Investments | 68.3m |
Receivables | 94.3m |
Other Current Assets | 165.7m |
Non-Current Assets | 428.4m |
Long-Term Investments | 5.2m |
PP&E | 389m |
Intangibles | 15m |
Other Non-Current Assets | 19.2m |
Free Cash Flow Analysis
PolyPeptide Group AG
EUR | |
Free Cash Flow | EUR |
Earnings Waterfall
PolyPeptide Group AG
Revenue
|
338.8m
EUR
|
Cost of Revenue
|
-299.3m
EUR
|
Gross Profit
|
39.5m
EUR
|
Operating Expenses
|
-45.3m
EUR
|
Operating Income
|
-5.9m
EUR
|
Other Expenses
|
-13.7m
EUR
|
Net Income
|
-19.6m
EUR
|
PPGN Profitability Score
Profitability Due Diligence
PolyPeptide Group AG's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

Score
PolyPeptide Group AG's profitability score is 34/100. The higher the profitability score, the more profitable the company is.
PPGN Solvency Score
Solvency Due Diligence
PolyPeptide Group AG's solvency score is 48/100. The higher the solvency score, the more solvent the company is.

Score
PolyPeptide Group AG's solvency score is 48/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PPGN Price Targets Summary
PolyPeptide Group AG
According to Wall Street analysts, the average 1-year price target for
PPGN
is 30.6 CHF
with a low forecast of 19.19 CHF and a high forecast of 47.25 CHF.
Dividends
Current shareholder yield for PPGN is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
PPGN
stock under the Base Case scenario is
29.2
CHF.
Compared to the current market price of 16.7 CHF,
PolyPeptide Group AG
is
Undervalued by 43%.